Cita APA

Borthakur, G., Alvarado, Y., Ravandi-Kashani, F., Cortes, J., Estrov, Z., Faderl, S., . . . Giles, F. (2008). Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients With Refractory Hematologic Malignancies.

Chicago Style Citation

Borthakur, Gautam, et al. Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients With Refractory Hematologic Malignancies. 2008.

Cita MLA

Borthakur, Gautam, et al. Phase 1 Study of XL119, a Rebeccamycin Analog, in Patients With Refractory Hematologic Malignancies. 2008.